145 related articles for article (PubMed ID: 36596754)
21. Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program.
Rosário A; Sousa A; Marinho-Dias J; Medeiros R; Lobo C; Leça L; Coimbra N; Tavares F; Baldaque I; Martins G; Monteiro P; Henrique R; Sousa H
J Med Virol; 2023 Jan; 95(1):e28414. PubMed ID: 36541747
[TBL] [Abstract][Full Text] [Related]
22. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
23. Burden and Associated Genotype Patterns of High-Risk Human Papilloma Virus Infection and Cervical Cytology Abnormalities among Women in Central India.
Gupta S; Purwar S; Gupta P; Halder A; Gupta A; Pushpalatha K; John JH
Infect Dis Obstet Gynecol; 2022; 2022():3932110. PubMed ID: 35634175
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk.
Martinelli M; Giubbi C; Saderi L; Musumeci R; Perdoni F; Leone BE; Fruscio R; Landoni F; Piana A; Sotgiu G; Cocuzza CE
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674835
[TBL] [Abstract][Full Text] [Related]
25. Analysis of HPV Genotypes and Liquid-Based Cervical Cytology: Results from a Tertiary Academic Center in Northwestern Turkey.
Çalişkan E; Coşkun SK; Öztürk CE; Cangür Ş; Önail B
Jpn J Infect Dis; 2021 Jan; 74(1):69-72. PubMed ID: 32611975
[TBL] [Abstract][Full Text] [Related]
26. [Study on the genotyping of human papillomavirus using a new DNA liquid chip in women of high-risk group of Shandong province].
Liu M; Wang CX; Deng XM; Wang LS; Zhang J; Li W; Zheng GX; Wang JF
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 May; 28(5):487-90. PubMed ID: 17877181
[TBL] [Abstract][Full Text] [Related]
27. PCR-reverse dot blot human papillomavirus genotyping as a primary screening test for cervical cancer in a hospital-based cohort.
Kang Y; Sun P; Mao X; Dong B; Ruan G; Chen L
J Gynecol Oncol; 2019 May; 30(3):e29. PubMed ID: 30887754
[TBL] [Abstract][Full Text] [Related]
28. Prevalent distribution and survival outcome of HPV infection in patients with early-stage cervical cancer in Hangzhou, China.
Xu X; Feng T; Li D; Lou H; Lan H
BMC Infect Dis; 2022 Dec; 22(1):941. PubMed ID: 36522614
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus 16-positive uterine cervical squamous cell carcinoma with coinfection with human papillomavirus 34 has a lower incidence in lymph node metastasis than that without coinfection with human papillomavirus 34.
Michimata R; Watari H; Tomaru U; Sakuragi N; Ishizu A
Pathobiology; 2013; 80(5):259-64. PubMed ID: 23689419
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
Egli-Gany D; Spaar Zographos A; Diebold J; Masserey Spicher V; Frey Tirri B; Heusser R; Dillner J; Petignat P; Sahli R; Low N;
BMC Cancer; 2019 Jan; 19(1):111. PubMed ID: 30700274
[TBL] [Abstract][Full Text] [Related]
31. Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.
Castle PE; Schiffman M; Wheeler CM; Wentzensen N; Gravitt PE
Cancer Epidemiol Biomarkers Prev; 2010 Jul; 19(7):1675-81. PubMed ID: 20615885
[TBL] [Abstract][Full Text] [Related]
32. Human Papillomavirus Status in Primary Lesions and Pelvic Lymph Nodes and Its Prognostic Value in Cervical Cancer Patients with Lymph Node Metastases.
Chen P; Zhang W; Yang D; Zhang W; Gao S
Med Sci Monit; 2019 Mar; 25():1894-1902. PubMed ID: 30864560
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus genotyping by the DNA chip in the cervical neoplasia.
Park TC; Kim CJ; Koh YM; Lee KH; Yoon JH; Kim JH; Namkoong SE; Park JS
DNA Cell Biol; 2004 Feb; 23(2):119-25. PubMed ID: 15000752
[TBL] [Abstract][Full Text] [Related]
34. Multiple Human Papilloma Virus Infections and Their Impact on the Development of High-Risk Cervical Lesions.
Salazar KL; Zhou HS; Xu J; Peterson LE; Schwartz MR; Mody DR; Ge Y
Acta Cytol; 2015; 59(5):391-8. PubMed ID: 26674365
[TBL] [Abstract][Full Text] [Related]
35. [Risk stratification of type-specific human papillomavirus for cervical precancers: evidence from a cross-sectional study in Shenzhen].
Liu ZH; Lin W; Wang YY; Wu B; Yuan SX; Yao JL; Zhao XS; Chen B; Qiao YL; Zhao FH; Chen W; Hu SY
Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):757-763. PubMed ID: 30392340
[No Abstract] [Full Text] [Related]
36. Prevalence of Specific Types of Human Papiloma Virus in Cervical Intraepithelial Lesions and Cervical Cancer in Macedonian Women.
Aleksioska-Papestiev I; Chibisheva V; Micevska M; Dimitrov G
Med Arch; 2018 Feb; 72(1):26-30. PubMed ID: 29416214
[TBL] [Abstract][Full Text] [Related]
37. Risk stratification for cervical precancer and cancer by DH3-HPV partial genotyping and cytology in women attending cervical screening: A retrospective cohort study.
Fu Y; Li Y; Li X; Wang X; Lü W
J Med Virol; 2023 Feb; 95(2):e28482. PubMed ID: 36609841
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus genotype distribution among women with and without cervical cancer: Implication for vaccination and screening in Ghana.
Nartey Y; Amo-Antwi K; Hill PC; Dassah ET; Asmah RH; Nyarko KM; Agambire R; Konney TO; Yarney J; Damale N; Cox B
PLoS One; 2023; 18(1):e0280437. PubMed ID: 36656844
[TBL] [Abstract][Full Text] [Related]
39. Predicting treatment outcome in cervical diseases using liquid-based cytology, dynamic HPV genotyping and DNA cytometry.
Bollmann M; Várnai AD; Griefingholt H; Bánkfalvi A; Callenberg H; Speich N; Schmitt C; Bollmann R
Anticancer Res; 2006; 26(2B):1439-46. PubMed ID: 16619556
[TBL] [Abstract][Full Text] [Related]
40. Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype.
de Cremoux P; de la Rochefordière A; Savignoni A; Kirova Y; Alran S; Fourchotte V; Plancher C; Thioux M; Salmon RJ; Cottu P; Mignot L; Sastre-Garau X
Int J Cancer; 2009 Feb; 124(4):778-82. PubMed ID: 19035459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
